Cuba vs El Salvador: Liver cancer death rate
Cuba
3.96 deaths per 100,000 people
in 2021
El Salvador
4 deaths per 100,000 people
in 2018
Cuba rank
65th
El Salvador rank
63rd
Liver cancer death rate over time
- Cuba
- El Salvador
How they compare
El Salvador currently reports 4 deaths per 100,000 people against 3.96 deaths per 100,000 people in Cuba, a difference of 0.04 deaths per 100,000 people.
The two have swapped places 9 times across 24 shared years of data; in 1990 it was Cuba ahead.
Cuba ranks 65th and El Salvador ranks 63rd of 110 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.08 deaths per 100,000 people | 2.7 deaths per 100,000 people | 1.62 deaths per 100,000 people | El Salvador |
| 2000s | 4.22 deaths per 100,000 people | 4.66 deaths per 100,000 people | 0.4401 deaths per 100,000 people | El Salvador |
| 2010s | 4.22 deaths per 100,000 people | 4.51 deaths per 100,000 people | 0.2938 deaths per 100,000 people | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher liver cancer death rate, Cuba or El Salvador?
- El Salvador, at 4 deaths per 100,000 people against 3.96 deaths per 100,000 people in Cuba as of 2018.
- What is the difference in liver cancer death rate between Cuba and El Salvador?
- 0.04 deaths per 100,000 people, with El Salvador ahead.
- How many years of comparable data are there for Cuba and El Salvador?
- 24 years are reported by both, from 1990 to 2018.
- How do Cuba and El Salvador rank globally for liver cancer death rate?
- Cuba ranks 65th and El Salvador ranks 63rd of 110 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Liver cancer death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from liver cancer in both sexes in those aged all ages per 100,000 people.